Insmed's DPP1 inhibitor Brinsupri (brensocatib) has been recommended by the CHMP for the treatment of patients aged 12 and ...

The oral targeted therapy sevabertinib led to tumor reduction and manageable side effects in patients with HER2-mutant ...

Spotting ILDs may be challenging. Symptoms such as a dry cough, shortness of breath, and unexplained weight loss may go ...

Lung cancer remains the leading cause of cancer-related death in the United States. The good news is that early detection ...

San Antonio man beat 12-year-old son to death. Here's his prison sentence. Kenny Loggins Slams Donald Trump for Using "Danger ...

There are steps physicians can take to prepare their patients with pulmonary issues for the changing of the seasons.

The increasing knowledge of barrier tissue-resident memory macrophages and trained innate immunity (TII) will help develop both nontarget-specific and target-specific TII-based vaccine strategies.

More than two decades after the September 11 attacks, new research suggests that responders who worked amid the World Trade Center (WTC) dust and debris face nearly a 3-fold higher incidence of lung ...

Presented at the European Society for Medical Oncology, study results showed Datroway extended survival in breast cancer ...

The Health and Safety Executive (HSE) has given construction firms one week’s notice ahead of a “day of action” in Manchester ...

In the current study, the association between mRNA COVID vaccination and survival was strongest among patients whose tumors ...

EMA committee recommends approval of Insmed’s Brinsupri to treat non-cystic fibrosis bronchiectasis: Bridgewater, New Jersey Monday, October 20, 2025, 15:00 Hrs [IST] Insmed Inc ...